Resverlogix Corp clinical-stage biotechnology company... Show more
Industry Biotechnology
A.I.dvisor tells us that RVXCF and FULC have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RVXCF and FULC's prices will move in lockstep.
| Ticker / NAME | Correlation To RVXCF | 1D Price Change % | ||
|---|---|---|---|---|
| RVXCF | 100% | N/A | ||
| FULC - RVXCF | 25% Poorly correlated | +7.52% | ||
| TELIF - RVXCF | 23% Poorly correlated | +2.73% | ||
| ATNM - RVXCF | 22% Poorly correlated | -3.20% | ||
| NGNE - RVXCF | 21% Poorly correlated | +6.69% | ||
| IDYA - RVXCF | 20% Poorly correlated | +5.56% | ||
More | ||||